Drugs / DASIPROTIMUT-T
last change Dec 2012 re-read 2 minutes ago

DASIPROTIMUT-T

also known as BiovaxId

Vaccine

Developed for
non-Hodgkin lymphoma
Investigated by
Biovest International

Trials 1 · a red edge is where a trial was stopped

2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00091676 Jan 2000 → Dec 2012 non-Hodgkin lymphoma Biovest International Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as DASIPROTIMUT-T ChEMBL registry synonym — accepted as the source's own label CHEMBL2364642
Known as BiovaxId BiovaxId, an autologous tumor derived immunoglobulin idiotype vaccine” NCT00091676
Modality Vaccine “autologous tumor derived immunoglobulin idiotype vaccineNCT00091676